# Pomalidomide for Kaposi Sarcoma in People With or Without HIV

> **NCT01495598** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 28 (actual)

## Conditions studied

- Kaposi Sarcoma
- Sarcoma, Kaposi

## Interventions

- **DRUG:** Pomalidomide

## Key facts

- **NCT ID:** NCT01495598
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-10
- **Primary completion:** 2022-05-17
- **Final completion:** 2022-05-17
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01495598

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01495598, "Pomalidomide for Kaposi Sarcoma in People With or Without HIV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01495598. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*